Some studies indicated that the oligomeric form may exhibit a higher toxicity, since α-synuclein transgenic mice, as well as PD and dementia with Lewy bodies patients, demonstrated elevated levels of soluble, lipid-dependent oligomers of α-synuclein in the brain in comparison to the controls [113]. The gene discussed is SNCA; the disease is Parkinson disease.